CAR-T cell therapy works well in blood cancers, but many patients still become resistant. A key reason is the presence of CAR ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

An illustration of two blue-hued T cells next to one another against a dark background. Regulatory T cells, or T regs, make up the basis for a slew of biotech companies working to treat immunological ...

According to the American Cancer Society, colorectal cancer is the second leading cause of cancer death. Enrichment of regulatory T cells (T-regs) in solid cancers is generally associated with poor ...

Good managers set the tone for the whole team, encouraging positive behavior from everyone around them. In the November 5 Nature, scientists introduce a subtype of microglia that appears to do just ...

Dr. Simrit Parmar has developed cell therapies for the treatment of autoimmune diseases and inflammatory disorders. Parmar launched the biotech company Cellenkos in 2016 to accelerate the clinical ...